Skip to main navigation Skip to search Skip to main content

RAvVA:Phase I/II Randomised Trial of 5-Azacitidine versus 5-Azacitidine in Combination with Vorinostat in patients with Relapsed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy

  • Craddock, Charles (Principal Investigator)

Project Details

Short titleRAvVA:Phase I/II Randomised Trial of 5-Azacitidine versus 5-Azacitidine in Combination with Vorinostat in patients with Relapsed Acute Myeloid Leukaemia Ineligible for Intensive Chemotherapy
StatusFinished
Effective start/end date10/07/12 → 31/12/23

Funding

  • CELGENE INTERNATIONAL SARL